Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | XBP1 | P17861 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2601517 | 1.00 | L3MBTL1 (0.32) | L3MBTL1KDM4EATMMAPTMEN1 | |
| SCHEMBL10034187 | 0.89 | KDM4E (0.33) | L3MBTL1KDM4EATM | |
| SCHEMBL2601512 | 0.89 | KDM4E (0.33) | L3MBTL1KDM4EATM | |
| SCHEMBL2601475 | 0.89 | KDM4E (0.38) | L3MBTL1KDM4EATM | |
| SCHEMBL10034160 | 0.89 | KDM4E (0.38) | L3MBTL1KDM4EATM | |
| SCHEMBL14460414 | 0.89 | L3MBTL1 (0.32) | L3MBTL1KDM4EATMMAPTMEN1 | |
| SCHEMBL2601507 | 0.89 | KDM4E (0.32) | L3MBTL1KDM4EATM | |
| SCHEMBL14460277 | 0.89 | L3MBTL1 (0.32) | L3MBTL1KDM4EATMMAPTMEN1 | |
| SCHEMBL10034192 | 0.89 | KDM4E (0.32) | L3MBTL1KDM4EATM | |
| SCHEMBL10034203 | 0.88 | KDM4E (0.37) | L3MBTL1KDM4EATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8455867-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2013-06-04 | — | — | US | disclosed |
| US-8455867-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2013-06-04 | — | — | US | disclosed |
| US-8405074-B2 | — | — | 2013-03-26 | — | — | US | disclosed |
| US-8405074-B2 | — | — | 2013-03-26 | — | — | US | disclosed |
| US-20120097924-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2012-04-26 | — | — | US | disclosed |
| US-20120097924-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2012-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120097924-A1 | ORGANIC LIGHT-EMITTING DEVICE | KCNT1, KCNA1, TRPA1 | L3MBTL1 1115/4885KDM4E 1280/4885ATM 3573/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.